PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

WHO SE Asia Region Parliamentarians make stronger commitments

The momentum picked up in recent years with WHO declaring ‘reducing preventable maternal, child and neonatal deaths’ as a flagship programme in South-East Asia Region...
Continue Reading →
news

Merck’s Keytruda gets approval in China for advanced melanoma

Melanoma is one of the fastest growing malignant cancers in China, increasing at an annual rate of 3-5 percent, which makes it one of the deadliest diseases in the co...
Continue Reading →
news

Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific fin...
Continue Reading →
news

Wockhardt starts manufacturing and R&D facility in Dubai

With an aim to grow and further establish their international presence in pharmaceutical manufacturing, Wockhardt inaugurated a‘state-of-the-art’ manufacturing facili...
Continue Reading →
news

SanBio Receives $20 Million Grant From CIRM

CIRM is an agency of the State of California formed to accelerate the progress of regenerative medicine through a highly competitive grant program. Prospective grants...
Continue Reading →
news

Sales of Roche new drugs are surging. Will that be enough?

Quickening sales of Roche's newer medicines offset the impact of rising biosimilar competition during the second quarter, helping to drive a 7% year-over-year jump...
Continue Reading →
news

Gilead CEO Milligan out ahead of turnaround bid

In an unexpected statement ahead of its second quarter earnings release Wednesday evening, Gilead Sciences said its well-liked CEO John Milligan will step down and...
Continue Reading →
news

Positive Alzheimer’s results from Biogen, Eisai spark ‘cautious optimism’

Biogen and partner Eisai announced Wednesday that a once-failed experimental drug for Alzheimer's disease slowed cognitive decline in patients with early forms of ...
Continue Reading →
news

GSK signs $300M genetic testing deal

GSK and 23andMe will also work on earlier-stage programs. The partners plan to use 23andMe’s data to jointly discover drug targets. GlaxoSmithKline has made a $300 m...
Continue Reading →
news

WuXi STA’s Jinshan site passes fourth U.S. FDA inspection

The Jinshan facility is dedicated to the manufacture of small molecule innovative APIs and advanced intermediates, from kilo to metric ton scale – from preclinical an...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC